mounjaro tirzepatide approvazione italia (tirzepatide): meccanismo di azione ed effetti collaterali FDA APPROVA TIRZEPATIDE, FARMACO ANTIOBESITA'

Generics, and copycats Generic alternatives may debut as patents expire , particularly for Semaglutide in China in 2026

These symptoms also overlap with other conditions, so its worth testing before starting treatment

Other notable adverse effects include injection site reactions (typically mild), gallbladder problems including cholelithiasis, acute kidney injury (particularly with severe dehydration from gastrointestinal side effects), and hypersensitivity reactions including anaphylaxis and angioedema

Others experience constipation as food moves more slowly through the digestive tract

avoiding high-fat or spicy foods